ArticleBMC cardiovascular disorders2026
Incidence of arterial hypertension in Germany 2009-2018 based on prevalence data from 70 million patients from the statutory health insurance.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Incidence of arterial hypertension in Germany 2009-2018 based on prevalence data from 70 million patients from the statutory health insurance.BMC cardiovascular disorders · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHypertension is an important risk factor for cardiovascular diseases, morbidity and mortality. In Germany, elevated systolic blood pressure is associated with more than half of all cardiovascular deaths. Despite the importance of arterial hypertension, comprehensive incidence data in Germany are very limited, and no data on the mortality rate ratio (MRR) of hypertension have been reported. Our study is the first to provide estimates for all statutory health insurance members in Germany. The aim of this study was to determine the age-specific incidence of hypertension in men and women in Germany for the first time using this large prevalence dataset.
methodsWe estimated the incidence of arterial hypertension from 2009 to 2018 using the Illness-death model (IDM) and a partial differential equation (PDE) based on aggregated prevalence and mortality data. The dataset used comprised age- and sex-specific prevalence data from the Central Institute for Statutory Health Insurance (Zi) with about 70 million insured individuals, as well as mortality data from the Human Mortality Database. To obtain the parameters needed for calculating age- and sex-specific incidence curves, we repeatedly re-sampled the data (1,000 times; bootstrapping) and estimated these parameters in each run. This procedure ensured that the parameters - which form the basis of the incidence estimation - were stable and reliable, and it allowed us to quantify statistical uncertainty. Incidence rates for men and women were reported as median values with 95% confidence intervals.
resultsAt every age, men showed higher incidence rates than women. The maximum incidence (median of 1,000 bootstrap samples) was 763.34 per 10,000 person-years (95%-CI: 761.00-765.71) for men and 634.73 (95%-CI: 633.01-636.61) per 10,000 person-years for women in the middle of the 85–89 age interval.
conclusionThis study provides the first nationwide incidence estimates of arterial hypertension in Germany based on highly aggregated health data. The findings confirm higher incidence rates in men than in women across all ages.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.